One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 25 points (0.1%) at 17,526 as of Monday, May 23, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,545 issues advancing vs. 1,371 declining with 153 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Cigna ( CI), down 4.2%, Universal Health Services ( UHS), down 1.6% and DaVita HealthCare Partners ( DVA), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. HCA Holdings ( HCA) is one of the companies pushing the Health Services industry lower today. As of noon trading, HCA Holdings is down $0.87 (-1.1%) to $76.25 on light volume. Thus far, 923,427 shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $75.96-$77.09 after having opened the day at $76.63 as compared to the previous trading day's close of $77.12.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $30.0 billion and is part of the health care sector. Shares are up 14.0% year-to-date as of the close of trading on Friday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Abbott Laboratories ( ABT) is down $0.23 (-0.6%) to $37.37 on light volume. Thus far, 3.0 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 8.6 million shares. The stock has ranged in price between $37.27-$37.75 after having opened the day at $37.75 as compared to the previous trading day's close of $37.60.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Abbott Laboratories manufactures and sells health care products worldwide. Abbott Laboratories has a market cap of $54.7 billion and is part of the health care sector. Shares are down 16.3% year-to-date as of the close of trading on Friday. Currently there are 11 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Abbott Laboratories Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, CVS Health ( CVS) is down $0.66 (-0.7%) to $98.80 on average volume. Thus far, 2.9 million shares of CVS Health exchanged hands as compared to its average daily volume of 4.1 million shares. The stock has ranged in price between $98.77-$99.71 after having opened the day at $99.69 as compared to the previous trading day's close of $99.46.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. CVS Health has a market cap of $108.4 billion and is part of the health care sector. Shares are up 1.7% year-to-date as of the close of trading on Friday. Currently there are 17 analysts that rate CVS Health a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates CVS Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full CVS Health Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).